Helix BioPharma Corp. collaborator ProMab Biotechnologies Publishes Paper on Multiple Myeloma CAR-T

Source :: GlobeNewswire. September 12, 2018
Publication Year :: 2018
Abstract: RICHMOND HILL, Ontario, Sep 12, 2018 (GLOBE NEWSWIRE via COMTEX) -- Helix BioPharma Corp. (TSX:HBP), (FSE:HBP) ('Helix' or the 'Company'), an immuno-oncology company developing innovative drug candidates for the prevention [...]

Subjects :: Helix BioPharma Corp.
Cancer treatment
Biotechnology
Monoclonal antibodies
Multiple myeloma -- Care and treatment
Biological products industry
T cells
Banking, finance and accounting industries
Business

Tools